In human neuronal models of monogenic Alzheimer’s disease, APP and PSEN1 mutations disrupt lysosome function and autophagy, leading to impaired lysosomal proteolysis and defective autophagosome clearance. This evidence concerns the gene PSEN1 and early-onset autosomal dominant Alzheimer disease.